Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced

Related Keywords

Boston ,Massachusetts ,United States ,Marie Campinell ,Jonathan Pappas ,Lifesci Communications ,Corporate Communications ,Linkedin ,International Investors ,Nasdaq ,Cue Biopharma Inc ,Ono Pharmaceutical ,Selective Targeting ,